Response of differentiated but not anaplastic teratoma to interferon.

A Phase 2 trial was conducted using intramuscular lymphoblastoid interferon (IFN, Wellcome Research Laboratories), 4 MU per day, in 10 patients with chemotherapy-resistant teratomas. There was stabilisation of disease in 2 patients both of whom were in retrospect considered to have had differentiate...

Descripción completa

Detalles Bibliográficos
Autores principales: Rustin, G. J., Kaye, S. B., Williams, C. J., Newlands, E. S., Bagshawe, K. D., Toy, J. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1984
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976992/
https://www.ncbi.nlm.nih.gov/pubmed/6498061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976992/
https://www.ncbi.nlm.nih.gov/pubmed/6498061

Ejemplares similares